AI MARKET SCANNING

Longeveron Inc-A

🏛️ NASDAQ 📁 Health Technology 🏭 Biotechnology
AVG HISTORICAL GAP -4.54%
MAX GAP RECORD -13.85%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $LGVN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 12, 2026 Earnings Release 2026-08-12 (AFTER CLOSE)
-10.31%
May 13, 2026 Earnings Release 2026-05-13 (AFTER CLOSE)
+0.00%
Mar 17, 2026 Earnings Release 2026-03-17 (AFTER CLOSE)
-13.85%
Nov 04, 2025 Earnings Release 2025-11-04 (AFTER CLOSE)
+0.00%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
+0.00%
May 07, 2025 Earnings Release 2025-05-07 (AFTER CLOSE)
-2.01%
Nov 12, 2024 Earnings Release 2024-11-12 (AFTER CLOSE)
-5.22%
Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE)
-12.26%

VOLATILITY & GAP BIAS

AVG GAP MOVE 5.7%
Bullish Gaps (2)
Bearish Gaps (7)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $LGVN

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors….

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗